Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02535923 · ClinicalTrials.gov registry record · NA
CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02535923: Completed NA study, sponsored by VA Office of Research and Development.
NCT02535923 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02535923, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The goal of this project is to develop guidelines for the clinical tailoring of Cognitive Behavioral Therapy for Insomnia (CBT-I) for Veterans with psychotic disorders and insomnia, and to test the acceptability, feasibility, and preliminary efficacy of CBT-I for improving sleep-related functional outcomes in this population.
Primary Outcome
ISI score; scored on a scale of 0 to 28, with higher scores indicating worse insomnia severity.
Interventions
- BEHAVIORAL Health and Wellness
- BEHAVIORAL Cognitive Behavioral Therapy-Insomnia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2021-04-20 |
| Phase | NA |
What the finished NCT02535923 record still lists
NCT02535923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Health and Wellness is the first listed.
NCT02535923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02535923 about?
NCT02535923 is a clinical study titled "CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes". The goal of this project is to develop guidelines for the clinical tailoring of Cognitive Behavioral Therapy for Insomnia (CBT-I) for Veterans with psychotic disorders and insomnia, and to test the acceptability, feasibility, and preliminary efficacy of CBT-I for improving sleep-related functional o...
What is the current status of trial NCT02535923?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2018-03-01. Estimated completion is 2021-04-20.
What interventions are being tested in trial NCT02535923?
The interventions under investigation include: Health and Wellness (BEHAVIORAL), Cognitive Behavioral Therapy-Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT02535923?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02535923's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI